Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06399315 Org: User:
Start: 07/28/23 End: 11/30/24 Due: 11/30/25

Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06787131 Org: User:
Start: 05/21/24 End: 01/31/25 Due: 01/31/26

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06366789 Org: User:
Start: 04/30/24 End: 12/31/27 Due: 12/31/28

Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06780124 Org: User:
Start: 04/12/24 End: 06/30/25 Due: 06/30/26

A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT06708897 Org: User:
Start: 01/31/25 End: 04/30/28 Due: 04/30/29